Navigation Links
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix
Date:11/5/2009

PARSIPPANY, N.J., Nov. 5 /PRNewswire/ -- DSM Pharmaceutical Products today announced that it has made a manufacturing alliance with Galenix, Saint Jean D'Illac, France, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis.

DSM and Galenix will collaborate on business development opportunities co-marketing Galenix drug delivery technologies, based on the strength of Galenix in drug product development and clinical services and DSM in process development, scale up and commercial scale pharmaceutical manufacturing.

Pieter de Geus, Senior Vice President, R&D stated, "These innovative drug delivery technologies enhance our offering in the field of pharmaceutical development services and complement our portfolio of drug delivery technologies. The collaboration with Galenix clearly demonstrates DSM's commitment to bringing improved drug delivery to markets globally."

Hans Engels, President of DSM Pharmaceuticals, Inc. commented, "The alliance brings out the best of both parties. Combining innovative formulations with flawless transition into commercial products creates an attractive value proposition for any drug company."

Jerome Besse, CEO of Galenix concurred with the DSM comments, and further added, "This is truly a win-win situation. Galenix is privileged in working with DSM to generate value for our customers. The partnership fits with our strategic intention of expanding service offerings to the North America market, and also with DSM's expansion of sales & marketing focus in Europe."

No financial terms were disclosed.

Galenix

Founded in 1993 by CEO Jerome Besse, Galenix is ranked in the top European leaders for pharmaceutical R&D and drug delivery systems. Galenix provides comprehensive pharmaceutical development services to healthcare companies, from the sourcing of Active Pharmaceutical I
'/>"/>

SOURCE DSM Pharmaceutical Products
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
2. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
3. ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
4. Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
5. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
7. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
8. Transdel Pharmaceuticals to Present at Two Investor Conferences
9. Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy
10. Amylin Pharmaceuticals to Webcast Third Quarter Results
11. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 PureTech , ... tackling big healthcare problems, announced today the closing ... with participation from Invesco Perpetual, a $120 Billion ... to drive PureTech,s existing pipeline forward and to ... has the scientific creativity to really go for ...
(Date:10/19/2014)... Latin American hardware encryption display market report defines and ... forecast of revenue. This market was valued at $165.0 ... million by 2018, at a CAGR of 70.3% from ... the Latin American hardware encryption market report to get ... provides a glimpse of the segmentation of the market, ...
(Date:10/19/2014)... 2014 The Asian Automatic patient billing ... analysis and forecast of revenue. The Automatic patient billing ... $463.9 million by 2018, at a developing CAGR of ... TOC of the Asian Automatic patient billing market, to ... also provides a glimpse of the segmentation of this ...
(Date:10/19/2014)... October 19, 2014 The report ... & Homeland Security), Technology, Payload, Type & by ... segments the global unmanned ground vehicle market into ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
Breaking Biology Technology:PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 2Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 5
... N.J., Sept. 17 Medarex, Inc.,(Nasdaq: MEDX ) ... the UBS,Global Life Sciences Conference at 4:30 p.m. Eastern ... webcast live and will be available in,the Investor Relations ... archived edition of the presentation will be available following ...
... Former Chair Of Psychology Department At Harvard University,Joins Panel Of ... ... Neurological Testing Company, BERKELEY, Calif., Sept. 17 NeuroFocus, ... for marketing,research, announced that professor Stephen Kosslyn, Ph.D. has joined ...
... LOUIS, Sept. 17 Sigma-Aldrich Corporation,(Nasdaq: SIAL ) ... Sciences,Conference on Wednesday, September 24th at 8:30 AM ET ... may listen via live audio broadcast over the,Internet available ... to access this file. For the webcast on, http://ir.sigmaaldrich.com ...
Cached Biology Technology:Neurofocus Appoints Stephen Kosslyn to Its Advisory Board 2
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2New perspectives for development of an RSV vaccine 2
... A great deal of science learning takes place ... for example, and through TV programs, books, and online ... new from the National Research Council, recommends ways museum ... foster science learning for people of all ages, backgrounds, ...
... An Australian method for assessing the environmental impact of ... agencies worldwide. Aspects of the ,ecological risk assessment, ... Ecuador, and the Western and Central Pacific, and by ... The method was developed in research led by Dr ...
... Two junior researchers from Ludwig-Maximilians-Universitt (LMU) in ... the European Research Council (ERC). Professor Jens Michaelis, ... David Vhringer, Institute of Immunology, shall receive grants ... five years. With its Starting Grant, the ERC ...
Cached Biology News:World interest in Australian fishery impact test 2LMU Munich researchers highly endowed with EU funding 2
... 200 IS System is ideal for developing ... reagents. This system contains the new, improved, ... Luminex. The user can design specific templates ... system has fully integrated graphing and data ...
...
... GeneSwitch Cell Lines stably express the ... cell line is functionally tested for ... the expression control vector pGene/V5-His/lacZ and ... treatment with mifepristone (Figure 1). These ...
... for 10 separate biopanning experiments, complexity ... gIII Sequencing Primer (100 pmol), for ... Primer (100 pmol), for automated DNA ... Control target (Streptavidin) and Elutant (Biotin), ...
Biology Products: